Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
2012
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
The Design of Scaffolds for Use in Tissue Engineering. Part I. Traditional Factors
2001 Standout
Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model
2001
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary
2016
Composition Options for Tissue-Engineered Bone
2002
Bone Disease after Renal Transplantation
2006
Interventions for preventing bone disease in kidney transplant recipients: A systematic review of randomized controlled trials
2005
High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death
2008
Variation in Serum and Plasma PTH Levels in Second-Generation Assays in Hemodialysis Patients: A Cross-sectional Study
2008
Nervous System Complications in Uremia
1988
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
2002 Standout
Scaffolds in tissue engineering bone and cartilage
2000 Standout
Association of Changes in Bone Remodeling and Coronary Calcification in Hemodialysis Patients: A Prospective Study
2008
Precision extruding deposition (PED) fabrication of polycaprolactone (PCL) scaffolds for bone tissue engineering
2009
Oral Phosphate Binders in Patients with Kidney Failure
2010
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
A Controlled Study of Vitamin D3 to Prevent Bone Loss in Renal-Transplant Patients Receiving Low Doses of Steroids
2004
Mortality risk among hemodialysis patients receiving different vitamin D analogs
2006
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Growth Factor Delivery for Tissue Engineering
2000
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
Hydrogels for tissue engineering: scaffold design variables and applications
2003 Standout
Long-term fracture risk following renal transplantation: a population-based study
2003
Innovative tissue engineering structures through advanced manufacturing technologies
2004
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats
2007
Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis
2005
Exercise Standards for Testing and Training
2013 Standout
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Vitamin D Deficiency
2007 Standout
Vitamin D Deficiency and Associated Factors in Hemodialysis Patients
2008
Pre-clinical in vivo evaluation of orthopaedic bioabsorbable devices
2000
Cinacalcet HCl and Concurrent Low-dose Vitamin D Improves Treatment of Secondary Hyperparathyroidism in Dialysis Patients Compared with Vitamin D Alone
2008
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder
2007 Standout
Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy
2006
Designing Biomaterials to Direct Biological Responses
1999
The Effect of Raloxifene Treatment in Postmenopausal Women with CKD
2008
VITAMIN D IN HEALTH AND DISEASE: Vitamin D for Health and in Chronic Kidney Disease
2005
Chronic kidney disease
2011 Standout
Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy
2003
Porosity of 3D biomaterial scaffolds and osteogenesis
2005 Standout
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis
2008
The Effect of Combined Calcium and Vitamin D3 Supplementation on Serum Intact Parathyroid Hormone in Moderate CKD
2009
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial
2010
Acute Renal Failure
1996 Standout
Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
2008
Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients
2008
Trends in Mineral Metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004
2008
Racial differences in bone mineral density and bone loss among end-stage renal disease patients
1999
Biomaterial developments for bone tissue engineering
2000 Standout
Can DXA Predict Fractures in Renal Transplant Patients?
2008
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Renal Osteodystrophy, Phosphate Homeostasis, and Vascular Calcification
2007
Bone mineral density and bone histomorphometry in children on long-term dialysis
2007
Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure
2007
3D bioprinting of tissues and organs
2014 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study
2008
Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients
2007
Sevelamer Controls Parathyroid Hormone–Induced Bone Disease as Efficiently as Calcium Carbonate without Increasing Serum Calcium Levels during Therapy with Active Vitamin D Sterols
2005
Treatment with Vitamin D and Calcium Reduces Bone Loss after Renal Transplantation
2002
Association of Bone Activity, Calcium Load, Aortic Stiffness, and Calcifications in ESRD
2008
Bone mineral density changes within six months of renal transplantation
2003
Pitfalls of Measuring Total Blood Calcium in Patients with CKD
2008
Vitamin D Status in Renal Transplant Recipients
2007
The role of collagen in bone strength
2005
Performance of degradable composite bone repair products made via three‐dimensional fabrication techniques
2003
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis
2005
Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors
2005
Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease
2011
Development of tissue scaffolds using selective laser sintering of polyvinyl alcohol/hydroxyapatite biocomposite for craniofacial and joint defects
2004
Activated Injectable Vitamin D and Hemodialysis Survival
2005
Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy
2006
Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D
2006
Prevalence and risk factors for osteopenia in dialysis patients
1996
Atherosclerosis of the ascending aorta is a predictor of renal dysfunction after cardiac operations
1999
Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism
1999
An initial investigation of photocurable three-dimensional lactic acid based scaffolds in a critical-sized cranial defect
2003
25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients
2008
Electrospun silk-BMP-2 scaffolds for bone tissue engineering
2006
Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism
2005
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study
2001
Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis
2007
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
The impact of the assay for measuring albumin on corrected ('adjusted') calcium concentrations
2009
Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
2006
Role of Hyperphosphatemia and 1,25-Dihydroxyvitamin D in Vascular Calcification and Mortality in Fibroblastic Growth Factor 23 Null Mice
2007
Porous scaffold design for tissue engineering
2005 Standout
K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients
2008
Fabrication of poly(α‐hydroxy acid) foam scaffolds using multiple solvent systems
2001
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism
2010
Osteoporosis after solid organ and bone marrow transplantation
2003
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism
2005
Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients
2007
Chitosan–alginate hybrid scaffolds for bone tissue engineering
2004
Intravenous Pamidronate as Treatment for Osteoporosis after Heart Transplantation: A Prospective Study
2001
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
2007
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
2009
Intravenous Paricalcitol for Treatment of Secondary Hyperparathyroidism in Children on Hemodialysis
2007
Hydrogels with tunable stress relaxation regulate stem cell fate and activity
2015 Standout
Microarchitectural and mechanical characterization of oriented porous polymer scaffolds
2002
Osteoporosis in the elderly with chronic kidney disease
2006
Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4)
2005
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery
2005 Standout
Chronic Kidney Disease
2016 Standout
Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl
2005
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Phosphate Metabolism in the Setting of Chronic Kidney Disease: Significance and Recommendations for Treatment
2007
Kidney Disease: Improving Global Outcomes
2009
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
Hydrogels in Biology and Medicine: From Molecular Principles to Bionanotechnology
2006 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
2011
Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease
2007
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
2014
3D Fabrication of Polymeric Scaffolds for Regenerative Therapy
2016
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
The elderly patient with acute renal failure.
1995
Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
2008
Freezing as a Path to Build Complex Composites
2006 StandoutScience
The Tumor Lysis Syndrome
2011 Standout
Electrospinning of polymer nanofibers for tissue regeneration
2014
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
2009
Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states
2002
Hydrogels for Tissue Engineering
2001 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Tissue-engineered autologous bladders for patients needing cystoplasty
2006 Standout
Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals
2014 Standout
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Synthesis and properties of photocross-linked poly(propylene fumarate) scaffolds
2001
25-Hydroxyvitamin D Deficiency and Diabetes Predict Reduced BMD in Patients With Chronic Kidney Disease
2006
Alterations in a redox oxygen sensing mechanism in chronic hypoxia
2001
Porous chitin matrices for tissue engineering: Fabrication and in vitro cytotoxic assessment
2001
Synthesis and Characterization of Injectable Poly(N-isopropylacrylamide)-Based Hydrogels That Support Tissue Formation in Vitro
1999
Vitamin D compounds for people with chronic kidney disease requiring dialysis
2009
Alendronate Prevents Further Bone Loss in Renal Transplant Recipients
2001
Differential Effects of Vitamin D Analogs on Vascular Calcification
2007
Acute renal failure in the patient undergoing cardiac operation
1994
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Blends of Poly-(ε-caprolactone) and Polysaccharides in Tissue Engineering Applications
2005
Chitin and chitosan: Properties and applications
2006 Standout
Bone metabolism and disease in chronic kidney disease
2003
3D Bioprinting of Vascularized, Heterogeneous Cell‐Laden Tissue Constructs
2014 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism
2003
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Safety and Efficacy of Risedronate in Patients With Age-Related Reduced Renal Function as Estimated by the Cockcroft and Gault Method: A Pooled Analysis of Nine Clinical Trials
2005
Creatine and Creatinine Metabolism
2000 Standout
Preoperative Renal Risk Stratification
1997
Works of Stuart M. Sprague being referenced
Engineering Bone Regeneration with Bioabsorbable Scaffolds with Novel Microarchitecture
1999
Abnormal Bone and Mineral Metabolism in Kidney Transplant Patients – A Review
2007
Possible involvement of advanced glycation end-products in bone resorption
1996
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl
2005
Maintenance of Bone Mass in Patients Receiving Dialytic Therapy
1993
Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings
2004
Impact of Ergocalciferol Treatment of Vitamin D Deficiency on Serum Parathyroid Hormone Concentrations in Chronic Kidney Disease
2007
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism
2003
Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study
2009
Inhibition of Parathyroid Hormone: A Dose Equivalency Study of Paricalcitol and Doxercalciferol
2005
Osteoporosis in chronic kidney disease
2004
Association of Relatively Low Serum Parathyroid Hormone With Malnutrition-Inflammation Complex and Survival in Maintenance Hemodialysis Patients
2010
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
2003
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4
2004
Suppression of parathyroid hormone secretion in hemodialysis patients: Comparison of paricalcitol with calcitriol
2001
Percutaneous bone biopsy in the diagnosis of renal osteodystrophy
2002
Safety and Efficacy of Long-Term Treatment of Secondary Hyperparathyroidism by Low-Dose Intravenous Calcitriol
1992
Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds
1998
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Higher Strength Lanthanum Carbonate Provides Serum Phosphorus Control With a Low Tablet Burden and Is Preferred by Patients and Physicians
2008
Calcium and Calcitriol Prophylaxis Attenuates Posttransplant Bone Loss
2004
Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD
2006
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease
2016
Effect of the vitamin D analogues paricalcitol and calcitriol on bone mineral in vitro
2000
Bone disease after kidney transplantation
2004
Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis or Peritoneal Dialysis
2007
Renal Osteodystrophy in Chronic Renal Failure
2002
Lanthanum Carbonate Reduces Phosphorus Burden in Patients with CKD Stages 3 and 4
2008
Increased Risk of Fracture in Patients Receiving Solid Organ Transplants
1999
Clinical Manifestations and Pathogenesis of Dialysis‐Related Amyloidosis
1996
Acute renal failure associated with cardiac operations
1989
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate
2007
Role of Vitamin D Deficiency in Chronic Kidney Disease
2007
Encephalopathy in Chronic Renal Failure Responsive to Deferoxamine Therapy
1986
60
2007
Aluminum inhibits bone nodule formation and calcification in vitro
1993
Treatment of renal osteodystrophy
2007
Parathyroid hormone-mediated aluminum deposition and egress in the rat
1980